Skip to main content

Advertisement

Log in

Hybrid Low-Grade Fibromyxoid Sarcoma and Sclerosing Epithelioid Fibrosarcoma of the Pancreas

  • Case Report
  • Published:
Journal of Gastrointestinal Cancer Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8

References

  1. Chew W, Benson C, Thway K, Hayes A, Miah A, Zaidi S, et al. Clinical characteristics and efficacy of chemotherapy in sclerosing epithelioid fibrosarcoma. Med Oncol. 2018;35(11):138–44. https://doi.org/10.1007/s12032-018-1192-6.

  2. Evans HL. Low-grade fibromyxoid sarcoma. (1987) A report of two metastasizing neoplasms having a deceptively benign appearance. Am J Clin Pathol 88(5):615–619. https://doi.org/10.1093/ajcp/88.5.615.

  3. Fletcher C, Bridge J, Hogendoorn P, et al. (2013) World Health Organization classification of tumours of soft tissue and bone: pathology and genetics of tumours of soft tissue and bone, 4th ed. Lyon, France: IARC Press.

  4. Meis-Kindblom JM, Kindblom LG, Enzinger FM. Sclerosing epithelioid fibrosarcoma: a variant of fibrosarcoma simulating carcinoma. Am J Surg Pathol. 1995;19(9):979–93. https://doi.org/10.1097/00000478-199509000-00001.

  5. Prieto-Granada C, Zhang L, Chen HW, Sung YS, Agaram NP, Jungbluth AA, et al. A genetic dichotomy between pure sclerosing epithelioid fibrosarcoma (SEF) and hybrid SEF/low-grade fibromyxoid sarcoma: a pathologic and molecular study of 18 cases. Genes Chromosomes Cancer. 2015;54(1):28–38. https://doi.org/10.1002/gcc.22215.

  6. Maretty-Nielsen K, Baerentzen S, Keller J, et al. (2013) Low-grade fibromyxoid sarcoma: incidence, treatment strategy of metastases, and clinical significance of the FUS gene. 2013:1-6. https://doi.org/10.1155/2013/256280.

  7. Colovic R, Grubor N, Misev M, et al. Fibromyxoid sarcoma of the pancreas. Srp Arh Celok Lek. 2008;136(3):158–61. https://doi.org/10.2298/SARH0804158C.

  8. Fujii S, Kawawa Y, Horiguchi S, Kamata N, Kinoshita T, Ogawa T. Low-grade fibromyxoid sarcoma of the small bowel mesentery: computed tomography and magnetic resonance imaging findings. Radiat Med. 2008;26(4):244–7. https://doi.org/10.1007/s11604-007-0214-7.

  9. Kim KJ, Seo JW. Intra-abdominal low-grade fibromyxoid sarcoma of the transverse mesocolon mimicking lymphoma. Jpn J Radiol. 2014;32(6):360–4. https://doi.org/10.1007/s11604-014-0305-1.

  10. Mendoza AS, O’Leary MP, Peng SK, et al. Low-grade fibromyxoid sarcoma of the sigmoid colon. Exp Mol Pathol. 2015;98(2):300–3. https://doi.org/10.1016/j.yexmp.2015.02.007.

  11. Park IJ, Kim HC, Yu CS, Kim JS, Jang SJ, Kim JC. Low-grade fibromyxoid sarcoma of the colon. Dig Liver Dis. 2007;39(3):274–7. https://doi.org/10.1016/j.dld.2006.01.015.

  12. Winfield HL, de las Casas L, Greenfield W, et al. Low-grade fibromyxoid sarcoma presenting clinically as a primary ovarian neoplasm: a case report. Int J Gynecol Pathol. 2007;26(2):173–6. https://doi.org/10.1097/01.pgp.0000228145.36807.43.

  13. Bai S, Jhala N, Adsay NV, Wei S. Sclerosing epithelioid fibrosarcoma of the pancreas. Ann Diagn Pathol. 2013;17(2):214–6. https://doi.org/10.1016/j.anndiagpath.2011.06.006.

  14. Carvalho EA, Bonomi DO, Pinho AJM, Salles PGO, Vieira HC. Primary sclerosing epithelioid fibrosarcoma of the pleura. J Bras Pneumol. 2017;43(6):490–1 https://doi.org/10.1590/s1806-37562017000000198.

    Article  Google Scholar 

  15. Ertoy Baydar D, Kosemehmetoglu K, Aydin O, Bridge JA, Buyukeren B, Aki FT. Primary sclerosing epithelioid fibrosarcoma of kidney with variant histomorphologic features: report of 2 cases and review of the literature. Diagn Pathol. 2015;10:186 https://doi.org/10.1186/s13000-015-0420-z.

    Article  Google Scholar 

  16. Frattini JC, Sosa JA, Carmack S, Robert ME. Sclerosing epithelioid fibrosarcoma of the cecum: a radiation-associated tumor in a previously unreported site. Arch Pathol Lab Med. 2007;131(12):1825–8. https://dx.doi.org/. https://doi.org/10.1043/1543-2165.

  17. Evans HL. Low-grade fibromyxoid sarcoma: a clinicopathologic study of 33 cases with long-term follow-up. Am J Surg Pathol. 2011;35(10):1450–62. https://doi.org/10.1046/j.1365-2559.1998.00530.x.

  18. Baheti AD, Tirumani SH, Rosenthal MH, Howard SA, Shinagare AB, Ramaiya NH, et al. Myxoid soft-tissue neoplasms: comprehensive update of the taxonomy and MRI features. Am J Roentgenol. 2015;204(2):374–85. https://doi.org/10.2214/AJR.14.12888.

  19. Hwang S, Kelliher E, and Hameed M. (2012) Imaging features of low-grade fibromyxoid sarcoma (Evans tumor). 41(10):1263-72. https://doi.org/10.1007/s00256-012-1417-2.

  20. Torriani M, Etchebehere M, Amstalden EM, Ouellette H. Magnetic resonance imaging of low-grade fibromyxoid sarcoma. Clinics. 2006;61(3):267–70 https://doi.org/10.1590/S1807-59322006000300012.

    Article  Google Scholar 

  21. Eyden BP, Manson C, Banerjee SS, Roberts IS, Harris M. Sclerosing epithelioid fibrosarcoma: a study of five cases emphasizing diagnostic criteria. Histopathology. 1998;33(4):354–60. https://doi.org/j.1365-2559.1998.00530.x.

  22. Christensen D, Ramsamooj R, Gilbert TJ. Sclerosing epithelioid fiberosarcoma: short T2 on MR imaging. Skelet Radiol. 1997;26(10):619–21. https://doi.org/10.1007/s002560050297.

  23. Yue Y, Liu Y, Song L, Chen X, Wang Y, Wang Z. MRI findings of low-grade fibromyxoid sarcoma: a case report and literature review. BMC Musculoskelet Disord. 2018;19(1):65. https://doi.org/10.1186/s12891-018-1976-z.

  24. Sargar K, Kao SC, Spunt SL, Hawkins DS, Parham DM, Coffin C, et al. MR and CT imaging of low-grade fibromyxoid sarcoma in children: a report from the children’s oncology group study ARST0332. Am J Roentgenol. 2015;205(2):414–20. https://doi.org/10.2214/AJR.14.13972.

  25. Luo Y, Hu W, Wu H, Xue H, Huo L, Li F, et al. 18F-fluorodeoxyglucose PET/CT features and correlations with histopathologic characteristics in sclerosing epithelioid fibrosarcoma. Int J Clin Exp Pathol. 2014;7(10):7278–85.

  26. Arbajian E, Puls F, Magnusson L, et al. F. (2014). Recurrent EWSR1-CREB3L1 gene fusions in sclerosing epithelioid fibrosarcoma. Am J Surg Pathol 38(6):801–808. https://doi.org/10.1097/PAS.0000000000000158.

  27. Mok Y, Pang YH, Sanjeev JS, Kuick CH, Chang KT. Primary renal hybrid low-grade fibromyxoid sarcoma-sclerosing epithelioid fibrosarcoma: an unusual pediatric case with EWSR1-CREB3L1 fusion. Pediatr Dev Pathol. 2018;21(6):574–9. https://doi.org/10.1177/1093526617754030.

  28. Doyle LA, Wang WL, Dal Cin P, et al. MUC4 is a sensitive and extremely useful marker for sclerosing epithelioid fibrosarcoma. Am J Surg Pathol. 2012;36(10):1444–51. https://doi.org/10.1097/PAS.0b013e3182562bf8.

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Spencer C Behr MD.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kramer, S.P., Bowman, C.J., Wang, Z.J. et al. Hybrid Low-Grade Fibromyxoid Sarcoma and Sclerosing Epithelioid Fibrosarcoma of the Pancreas. J Gastrointest Canc 51, 1025–1029 (2020). https://doi.org/10.1007/s12029-020-00369-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12029-020-00369-0

Navigation